Alaina Hanlon, PhD
Co-Founder, President & CEO
Alaina Hanlon, President & CEO, brings to PhenotypeIT, Inc. over 10 years of expertise in the development of products and services that asses risk and predict their long term effects. As President & CEO of PhenotypeIT, Dr. Hanlon is responsible for translating strategy into operations and aligning operations for optimal value creation. Prior to PhenotypeIT, she co-founded Condition Engineering, Inc., a technology firm specializing in the design and implementation of Condition & Structural Health Monitoring Systems, and has worked for organizations such as NASA, General Electric, and Nichols Portland. As a small business owner, Dr. Hanlon has firsthand knowledge of the burden that rising health care costs place on an employer. After launching her first business, she focused on her passion of prevention and created a company that helps businesses manage and reduce their health care costs by identifying the leading modifiable issues facing the Organization. Throughout her career, Dr. Hanlon has received numerous awards and recognition for her work in the area of engineering, entrepreneurism and innovation including the 2010 UMass College of Engineering Outstanding Junior Alumni Award. Dr. Hanlon received her Bachelors of Science from Maine Maritime Academy and Master’s and PhD in mechanical engineering from the University of Massachusetts, Amherst.
Steven Grinspoon, M.D.
Co-Founder and Medical Advisor
Steven Grinspoon is Professor of Medicine and Director of the Massachusetts General Hospital Program in Nutritional Metabolism and an expert on metabolic and neuroendocrine dysregulation in undernutrition and obesity. Dr. Grinspoon has pursued a long-standing interest in nutrition and metabolism after completing an endocrine fellowship at the MGH. He is a funded NIH researcher focusing his efforts on the utilization of extensive phenotyping in the area of body composition, fat distribution, and clinical consequences of abnormal fat distribution. Dr. Grinspoon has been the primary investigator on studies identifying in statistical modeling the association of body composition and the risk for cardiovascular disease, diabetes, osteoporosis, and metabolic syndrome. He has extensive experience working with children, adolescents and older patients and the effects their body composition has on their current and future health condition. Dr. Grinspoon has been highly successful as a clinical investigator and mentor to researchers in nutritional metabolism, was elected to the American Society of Clinical Investigators in 2005, and received an award for outstanding investigator of the year in 2005 from the American Federation of Medical Research. He has also worked extensively with biopharmaceutical companies and has served as the principal investigator of a novel composition which utilized hypothalamic hormones to selectively reduce visceral fat. Dr. Grinspoon received his B.A. from Cornell University, his M.D. from University of Rochester School of Medicine and Dentistry, and an Honorary M.A. from Harvard University.
VP of Strategy
Robert Jahreis is a health information management professional with over 28 years of business and technical management experience for a variety of health care industry sectors including, disease management, managed care, physician, hospital academic and government entities. Prior to joining PhenotypeIT, Mr. Jahreis was Executive Director at Health Dialog Services Corporation. During his tenure at Health Dialog, Mr. Jahreis provided business and technical leadership on a variety of care management and member facing initiatives. Mr. Jahreis served as Vice President of Planning and Strategy for Ingenix where he lead product management and development activities for employer facing products including the development and deployment of the UnitedHealth Group Customer Reporting System. Mr. Jahreis has been serving as a Senior Fellow and Principal Investigator with the Health Innovation and Technology Lab at Columbia University leading research grants in predictive informatics and health information and technology management. Mr. Jahreis received his B.A. and M.A. in Sociology with a concentration in Organizational Analysis from Long Island University.
Chief Technology Officer
Peter Connolly is Chief Technology Officer of PhenotypeIT, Inc. and possesses an in-depth knowledge of its software products and services. He brings over 15 years of successful software development and leadership within the Healthcare, Financial Services, and Software Technology Industries to PhenotypeIT’s technology group. Prior to joining PhenotypeIT, Mr. Connolly was Principal Developer for Axeda, an internet based remote device management and security platform, where he provided technology development direction for the products. While at Axeda, he successfully achieved 250,000+ devices under management and surpassed platform performance levels of 10X during his employ. Mr. Connolly has also held leadership positions within the technology groups at Fidelity Investments, CVS/Caremark, Tallan, Hartford Insurance, and EMC. Mr. Connolly received a B.S. in Computer Science from Worcester Polytechnic Institute.